Table 2

Non-drug lipid lowering trials in subjects with coronary heart disease: angiographic trials confirming reduced CAD progression

TreatmentsDuration
Cholesterol: baseline mean 6.1–7.2 mmol/l.
Lipid reduction: cholesterol −9% to −53%, triglyceride −8% to −38%.
Lifestyle Heart Trial (1990)w7Diet, exercise, anti-smoking, stress management1 year
Program on the Surgical Control of the Hyperlipidemias (POSCH) (1990)w3Partial ileal bypass surgery5 years, 10 years
Heidelberg study (1992)w8Ddiet + exercise1 year
St Thomas’ Atherosclerosis Study (STARS) (1992)w9Diet3 years